Screener
NeoGenomics NEO Sales & Marketing
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| General and administrative | 63,613 | 71,747 | 129,354 | 139,954 |
| Research and development | 10,761 | 9,023 | 20,295 | 19,204 |
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
| Total operating expenses | 101,649 | 124,886 | 200,754 | 225,957 |
| LOSS FROM OPERATIONS | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's sales & marketing?
- NeoGenomics (NEO) reported sales & marketing of $27.28M in Q2 2026.
- How has NeoGenomics's sales & marketing changed year-over-year?
- NeoGenomics's sales & marketing increased by 13.3% year-over-year, from $24.08M to $27.28M.
- What is the long-term trend for NeoGenomics's sales & marketing?
- Over 4 years (2021 to 2025), NeoGenomics's sales & marketing has grown at a 10.1% compound annual growth rate (CAGR), from $62.59M to $92.01M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about NeoGenomics's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude